116 related articles for article (PubMed ID: 7003264)
21. Common expression of melanoma tumor-associated antigens recognized by human tumor infiltrating lymphocytes: analysis by human lymphocyte antigen restriction.
Hom SS; Topalian SL; Simonis T; Mancini M; Rosenberg SA
J Immunother (1991); 1991 Jun; 10(3):153-64. PubMed ID: 1868040
[TBL] [Abstract][Full Text] [Related]
22. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.
Gupta RK; Silver HK; Reisfeld RA; Morton DL
Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806
[TBL] [Abstract][Full Text] [Related]
23. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma.
Carrel S; Schreyer M; Gross N; Zografos L
Anticancer Res; 1990; 10(1):81-9. PubMed ID: 1692197
[TBL] [Abstract][Full Text] [Related]
24. An investigation concerning tumor cell antigenicity of hamster malignant melanoma utilizing heterologous antiserum.
Gulmen S
J Oral Pathol; 1976 Nov; 5(6):325-33. PubMed ID: 826609
[TBL] [Abstract][Full Text] [Related]
25. Antibodies and antigen expression in human melanoma detected by the immune adherence test.
Cornain S; de Vries JE; Collard J; Vennegoor C; van Wingerden I; Rümke P
Int J Cancer; 1975 Dec; 16(6):981-97. PubMed ID: 1104492
[TBL] [Abstract][Full Text] [Related]
26. Indirect rosette microassay to characterize human melanoma-associated antigens recognized by operationally specific xenoantisera.
Imai K; Ferrone S
Cancer Res; 1980 Jul; 40(7):2252-6. PubMed ID: 6966965
[TBL] [Abstract][Full Text] [Related]
27. Immune responses induced by human malignant melanoma in the rabbit.
Goodwin DP; Hornung MO; Leong SP; Krementz ET
Surgery; 1972 Nov; 72(5):737-43. PubMed ID: 4117015
[No Abstract] [Full Text] [Related]
28. Heterogeneity of HLA-A,B, Ia-like, and melanoma-associated antigen expression by human melanoma cell lines analyzed with monoclonal antibodies and flow cytometry.
Burchiel SW; Martin JC; Imai K; Ferrone S; Warner NL
Cancer Res; 1982 Oct; 42(10):4110-5. PubMed ID: 7049355
[TBL] [Abstract][Full Text] [Related]
29. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
[TBL] [Abstract][Full Text] [Related]
30. Surface antigenic characteristics of human glial brain tumor cells.
Wikstrand CJ; Mahaley MS; Bigner DD
Cancer Res; 1977 Dec; 37(12):4267-75. PubMed ID: 72598
[TBL] [Abstract][Full Text] [Related]
31. The use of non-human primates for production of antisera to human tumor-associated antigens.
Stuhlmiller GM; Mohanakumar T; Metzgar RS; Seigler HF
J Immunol Methods; 1976; 12(3-4):267-74. PubMed ID: 823260
[TBL] [Abstract][Full Text] [Related]
32. Heterogeneity of human melanoma-associated antigens defined by monoclonal antibodies and conventional xenoantisera.
Wilson BS; Kay NE; Imai K; Ferrone S
Cancer Immunol Immunother; 1982; 13(1):69-74. PubMed ID: 7159874
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical detection of antigen in human primary and metastatic melanomas by the monoclonal antibody 140.240 and its possible prognostic significance.
Natali PG; Roberts JT; Difilippo F; Bigotti A; Dent PB; Ferrone S; Liao SK
Cancer; 1987 Jan; 59(1):55-63. PubMed ID: 3539308
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibodies to human melanoma associated antigens: study of their specificity and visualization at the cellular level of the antigenic distribution.
Libert A; Ghanem G; Arnould R; Vercammen-Grandjean A; Carrel S; Lejeune F
Anticancer Res; 1983; 3(4):219-25. PubMed ID: 6576727
[TBL] [Abstract][Full Text] [Related]
35. Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies.
Dippold WG; Lloyd KO; Li LT; Ikeda H; Oettgen HF; Old LJ
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6114-8. PubMed ID: 6934537
[TBL] [Abstract][Full Text] [Related]
36. Biochemical characterization of human melanoma cell surfaces: dissection with monoclonal antibodies.
Mitchell KF; Fuhrer JP; Steplewski Z; Koprowski H
Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7287-91. PubMed ID: 6938976
[TBL] [Abstract][Full Text] [Related]
37. Solubilization and partial isolation of human melanoma tumor-associated antigens.
Stuhlmiller GM; Green RW; Seigler HF
J Natl Cancer Inst; 1978 Jul; 61(1):61-7. PubMed ID: 276639
[TBL] [Abstract][Full Text] [Related]
38. Class 1 (unique) tumor antigens of human melanoma. Identification of a 90,000 dalton cell surface glycoprotein by autologous antibody.
Real FX; Mattes MJ; Houghton AN; Oettgen HF; Lloyd KO; Old LJ
J Exp Med; 1984 Oct; 160(4):1219-33. PubMed ID: 6237165
[TBL] [Abstract][Full Text] [Related]
39. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
40. The serologic response of patients with stage II melanoma to allogeneic melanoma cell vaccines.
Livingston PO; Kaelin K; Pinsky CM; Oettgen HF; Old LJ
Cancer; 1985 Nov; 56(9):2194-200. PubMed ID: 4052966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
